Dynavax Enters Into Supply and Option Agreement for Development of Universal Influenza Vaccine Novartis Will Contribute Trivalent Vaccine to the Collaboration BERKELEY, Calif.--(BUSINESS WIRE)--Dynavax Technologies Corporation (Nasdaq:DVAX - News) today announced an agreement with Novartis Vaccines and Diagnostics, Inc.
Emergent BioSolutions Awarded Two Grants from NIAID to Support Development of the Company's Recombinant Botuli The rBOT Grant is the First Government Award in Support of the Company's Botulinum Vaccine Program ROCKVILLE, Md.--(BUSINESS WIRE)--Emergent BioSolutions Inc.(NYSE:EBS - News) announced today that it has secured two grants totaling...
Emergent BioSolutions Awarded Two Grants from NIAID to Support Development of the Company's Recombinant Botuli Emergent BioSolutions Inc.(NYSE:EBS) announced today that it has secured two grants totaling over $4.5 million from The National Institute of Allergy and Infectious Diseases (NIAID) to fund the continued development of the company's rBOT...
Fallout From Failed AIDS Vaccine Could Dampen Research Experts worry infection fears might keep participants from trials HealthDay Reporter MONDAY, Nov.12 (HealthDay News) -- An experimental AIDS vaccine used in a recent trial may have placed participants at higher risk of infection...
Emergent BioSolutions and the University of Oxford Form Joint Venture to Develop an Advanced Tuberculosis Vacc - The University of Oxford and Emergent BioSolutions Inc.(NYSE:EBS) announced today that they have formed a joint venture, The Oxford-Emergent Tuberculosis Consortium Ltd.
(the 'Consortium'), to further develop MVA85A, the world's most...
As Parents Nix Vaccine, Childhood Whooping Cough Increases Incidence highest in states with loosest exemption policies, study finds HealthDay Reporter TUESDAY, Oct.10 (HealthDay News) -- More parents are refusing to have their children immunized against common childhood diseases, as some states...
USCIS Tightens Vaccination Requirements Full line of vaccines for Immigration and Naturalization ready at Passport Health BALTIMORE, July 23, 2008 /PRNewswire/ -- New vaccine requirements will affect anyone who is applying for an immigrant visa for entry into the U.S....
Emergent BioSolutions and University of Oxford join hands to develop TB vaccine The University of Oxford, through its technology transfer office, Isis Innovation, has exclusively licensed the MVA85A tuberculosis (TB) vaccine candidate and related technology to the consortium.The consortium will work with the...
New Research Finds Live Influenza Vaccine Is Just as Safe for HIV-Infected Children; Current Recommendation Ha AURORA, Colo., July 22 (AScribe Newswire) -- Between September and mid-November in 2004, 243 HIV-infected children ages 5 to 18 years, who were receiving antiretroviral therapy for their condition, were randomly assigned to receive either...
HPV vaccine to help fight cervical cancer In an effort to fast-track the spread of cervical cancer, the Ministry of Health recently introduced the HPV vaccine. Now available in the local market, the vaccine can be used by females within the age bracket of 9-26 years.
Revised Vaccination Recommendations for Upcoming Flu Season The Centers for Disease Control and Preventions Advisory Committee on Immunization Practices (ACIP) has new and updated recommendations for the use of influenza vaccine and antiviral agents for the upcoming 2008-2009 flu season.The...
Dr. Gott: Difficulty finding shingles vaccine Dear Dr.Gott: I was able to convince my mother to get the shingles vaccine, but her doctor wouldnt administer it because of the short window in which it has to be given.
Mom and I searched for weeks to find a healthcare provider...
Family Doctor: Problem finding shingles vaccine ultimedia Sports Videos Lifestyle Headlines Singles events Looking back Your life EngagementsRecent Headlines Cooking classes Bridal Information Special Forms Anniversary Form Engagement Form Wedding Form Q: I was finally able to convince my...
Shingles vaccination can be an arduous journey Dear Dr.Gott: After reading your column about Zostavax, I had to write.
I was finally able to convince my mother to get the shingles vaccine, but her doctor would only give her a prescription for it.
He wouldn't administer it...
Dynavax inks flu vaccine deal with Novartis San Francisco Business Times - by Steven E.F.Brown Related News Dynavax to drop allergy program that failed test [East Bay] Bio pioneer takes new approach [San Francisco] Boost from Merck cuts Dynavax Technologies' Q1 loss [San Francisco]...
GeoVax Enters HIV/AIDS Vaccine Manufacturing Partnership GeoVax Partners with Vivalis for Use of Its Revolutionary EBx Technology to Manufacture Its MVA HIV/AIDS Vaccine Tuesday July 22, 1:30 am ET - Partnership creates worldwide strategic collaboration between Vivalis and GeoVax ATLANTA and...
GeoVax Partners with Vivalis for Use of Its Revolutionary EBx Technology to Manufacture Its MVA HIV/AIDS Vacci Partnership creates worldwide strategic collaboration between Vivalis and GeoVax ATLANTA and NANTES, France, July 22, 2008 /PRNewswire-FirstCall/ -- GeoVax Labs, Inc., an Atlanta based, biopharmaceutical company developing human ...
GeoVax Partners With Vivalis For Use Of Its Revolutionary Ebx® Technology To Manufacture Its MVA HIV/AIDS GeoVax Labs, Inc., an Atlanta based, biopharmaceutical company developing human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus) and other infectious agents, together with Vivalis, a French biopharmaceutical company...
Emergent BioSolutions and the University of Oxford form joint venture to develop an advanced Tuberculosis vacc Wellcome Trust and Aeras Global TB Vaccine Foundation have agreed to provide GBP 8 million in funding for Phase IIb clinical trial that is expected to commence in 2009 -- The vaccine candidate, MVA85A, has been granted orphan...
Emergent BioSolutions and the University of Oxford Form Joint Venture to Develop an Advanced Tuberculosis Vacc -- Wellcome Trust and Aeras Global TB Vaccine Foundation have agreed to provide GBP 8 million in funding for Phase IIb clinical trial that is expected to commence in 2009 -- The vaccine candidate, MVA85A, has been granted orphan...
Emergent BioSolutions and the University of Oxford Form Joint Venture to Develop an Advanced Tuberculosis Vacc - The University of Oxford and Emergent BioSolutions Inc.(NYSE:EBS) announced today that they have formed a joint venture, The Oxford-Emergent Tuberculosis Consortium Ltd.
(the 'Consortium'), to further develop MVA85A, the world's most...
Emergent BioSolutions and the University of Oxford Form Joint Venture to Develop an Advanced Tuberculosis Vacc The University of Oxford and Emergent BioSolutions Inc.(NYSE:EBS) announced today that they have formed a joint venture, The Oxford-Emergent Tuberculosis Consortium Ltd.
(the 'Consortium'), to further develop MVA85A, the world's most...
Dynavax Enters Into Supply and Option Agreement for Development of Universal Influenza Vaccine Novartis Will Contribute Trivalent Vaccine to the Collaboration BERKELEY, Calif.--(BUSINESS WIRE)--Dynavax Technologies Corporation (Nasdaq:DVAX) today announced an agreement with Novartis Vaccines and Diagnostics, Inc.for the...
FDA Approvals: KINRIX and Metvixia Describe the appropriate use of a new pediatric vaccine against diphtheria, tetanus, pertussis, and polio diseases.Describe the potential benefits of methyl aminolevulinate cream plus photodynamic therapy for the treatment of...
Vaccine Executive Staph Bakali Joins Genocea Biosciences' Board of Directors Director at Intercell AG and Former COO of ID Biomedical brings 20 years of vaccine development and management expertise CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genocea Biosciences, a leading vaccine discovery and development company,...
